The IPO Buzz: Jefferson Capital On Tap as All Eyes on Iran
Jefferson Capital (JCAP Proposed), a Minneapolis-based company that buys consumer debt, is on the marquee as the only large deal on the IPO Calendar for the last week of June. Wall Street is watching the headlines for news of Iran’s response to the U.S. bombing of its nuclear sites over the weekend. Iran said early today that the U.S. attacks “over the weekend have delivered an “irreparable blow” to the Nuclear Non-Proliferation Treaty — a bedrock, international agreement preventing the spread of atomic bombs,” Bloomberg reported on Monday, June 23, 2025.
The IPO of Jefferson Capital consists of 10 million shares at a price range of $15.00 to $17.00 to raise $160.0 million, if priced at the $16.00 mid-point of its range. Jefferson Capital is offering only 625,000 shares of stock in the IPO, while the selling shareholders are offering the remaining 9.375 million shares, according to the prospectus.
Jefferies and Keefe, Bruyette & Woods are the lead joint book-runners. Another seven investment banks are part of the joint book-running team.
Jefferson Capital is a profitable company that buys and collects consumer debt – typically charge-offs and insolvent consumer accounts – in the U.S., Canada, the U.K. and Latin America, according to the prospectus.
Jefferson Capital invests in installment loans, credit cards, auto loans and utility debt. Its focus is on distressed assets.
The rest of this week’s IPO Calendar consists of three small IPOs – one each from one each from Hong Kong, Cambodia and mainland China – aiming to raise $21.25 million combined. All three companies are profitable, according to their SEC filings. (Please see our IPO Calendar for information on these deals.)
(For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on the IPOScoop.com website.) Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board. To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message. Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions. Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums) is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading. The SCOOP Rating does not reflect the opinions of anyone associated with IPOScoop.com. The SCOOP ratings should not be taken as investment advice. The rating merely reflects the opinion of the professionals at the time of publication and is subject to last-minute changes due to market conditions, changes in a specific offering and other factors, such as changes in the proposed offering terms and the shifting of investor interest in the IPO. The information offered is taken from sources we believe to be reliable, but we cannot guarantee the accuracy.
Source: https://www.iposcoop.com/the-ipo-buzz-jefferson-capital-on-tap-as-all-eyes-on-iran/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
